Skip to main content

Table 1 Baseline characteristics of the study group

From: Validation of a hemoglobin A1c model in patients with type 1 and type 2 diabetes and its use to go beyond the averaged relationship of hemoglobin A1c and mean glucose level

 

Type 1

Type 2

All

n

15

15

30

Sex (% female)

8 (53)

7 (47)

15 (50)

Age (years)

36.4 ± 15.5

57.5 ± 15.8

47.0 ± 18.8

Duration of diabetes (years)

11.8 ± 11.3

10.1 ± 10.7

10.9 ± 10.8

BMI (kg/m2)

23.9 ± 5.6

29.1 ± 5.9

26.5 ± 6.2

C-peptide (nmol/l)

0.11 ± 0.17

1.10 ± 0.63

0.61 ± 0.68

Hemoglobin (g/l)

141 ± 11

139 ± 9

140 ± 10

Hematocrit (%)

41.1 ± 3.1

41.1 ± 2.7

41.1 ± 2.8

RBC (× 1012/l)

4.74 ± 0.38

4.65 ± 0.33

4.69 ± 0.35

WBC (× 109/l)

6.78 ± 1.75

7.40 ± 1.78

7.09 ± 1.76

Fe (μmol/l)

17.9 ± 8.6

16.6 ± 3.8

17.2 ± 6.6

Creatinine (μmol/l)

76 ± 27

68 ± 14

72 ± 22

  1. Data are mean ± SD.
  2. BMI, body mass index; RBC, erythrocyte count; WBC, leukocyte count.